Soleus Capital Master Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
TERN
Disclosed Ownership
212,710 shares
Ownership
0.2%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2026, 17:01:46 UTC
Date of event
31 Dec 2025
Previous filing
11 Feb 2025
SEC
View on sec.gov

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 0.2% ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN) on 31 Dec 2025."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN).
  • Disclosed ownership: 0.2%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 11 Feb 2025.
  • Current filing was accepted on 12 Feb 2026, 17:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy